EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income Statement

Revenue by Business Segment

2025-01-01 to 2025-12-31

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income StatementIncome statement for 2025-01-01 through 2025-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETUnited StatesEuropeRest of WorldJapanNet salesGross profitCost of salesOperating incomeOperating costs, net of other operating income (calculated)Selling, general, and administrative expensesResearch and development expensesIntellectual property agreement and certain litigation expenses (Note 3)Intangible assets impairment chargesChange in fair value of contingent consideration liabilities (Note 13)Other operating incomeRestructuring charges, separation costs, and other (Note 4)Other income (expense), net (calculated)Income from continuing operations before provision for income taxesNet incomeProvision for income taxes (Note 19)Income from discontinued operations, net of taxIncome from discontinued operations, net of taxIncome fromdiscontinuedoperations, net of tax$13.40 MOther income (expense), net (calculated)Other income,net (calculated)$8.70 MIncome from continuing operations before provision for income taxesPretax income$1.27 BNet salesNet sales$6.07 BGross profitGross profit$4.73 BOperating incomeOperating income$1.26 BNet incomeNet income$1.07 BUnited StatesUnited States$3.54 BOperating costs, net of other operating income (calculated)Operating costs,net (calculated)$3.47 BProvision for income taxes (Note 19)Provision for incometaxes (Note 19)$216.90 MSelling, general, and administrative expensesSelling, general, andadministrative expenses$2.09 BEuropeEurope$1.52 BCost of salesCost of sales$1.33 BResearch and development expensesResearch anddevelopment expenses$1.08 BRest of WorldRest of World$652.30 MIntellectual property agreement and certain litigation expenses (Note 3)Intellectual property agreementand certain litigation expenses$325.40 MJapanJapan$354.70 MIntangible assets impairment chargesIntangible assetsimpairment charges$40.00 MChange in fair value of contingent consideration liabilities (Note 13)Change in fair value of contingentconsideration liabilities (Note 13)−$12.50 MOther operating incomeOther operating income−$67.20 MRestructuring charges, separation costs, and other (Note 4)Restructuring charges, separationcosts, and other (Note 4)$19.10 M
Chart details

EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income Statement

Income statement for 2025-01-01 through 2025-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales
6,067,600,000 US dollars
Cost of sales
1,334,200,000 US dollars
Gross profit
4,733,400,000 US dollars
Operating costs, net of other operating income (calculated)
3,469,200,000 US dollars
Operating income
1,264,200,000 US dollars
Other income (expense), net (calculated)
8,700,000 US dollars
Income from continuing operations before provision for income taxes
1,272,900,000 US dollars
Provision for income taxes (Note 19)
216,900,000 US dollars
Net income
1,069,400,000 US dollars
United States
3,543,100,000 US dollars
Europe
1,517,500,000 US dollars
Japan
354,700,000 US dollars
Rest of World
652,300,000 US dollars
Selling, general, and administrative expenses
2,085,200,000 US dollars
Research and development expenses
1,079,200,000 US dollars
Intellectual property agreement and certain litigation expenses (Note 3)
325,400,000 US dollars
Change in fair value of contingent consideration liabilities (Note 13)
negative 12,500,000 US dollars
Restructuring charges, separation costs, and other (Note 4)
19,100,000 US dollars
Intangible assets impairment charges
40,000,000 US dollars
Other operating income
negative 67,200,000 US dollars
Income from discontinued operations, net of tax
13,400,000 US dollars. Reported below-tax contribution to net income.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
  • Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $1.07 B; to noncontrolling interests: −$4.10 M.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual Revenue by Business Segment Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

78.0%

Gross profit / revenue

Operating margin

20.8%

Operating profit / revenue

Cash conversion

149.2%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!